In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Adrian Mosquera, Clinical Hematologist at the University Hospital of Santiago de Compostela, about his research team’s novel machine learning model that incorporates patient characteristics and histological subtype into risk prognostication for mantle cell lymphoma (MCL). In addition, Dr. Mosquera shares more of his research utilizing artificial intelligence for designing more risk-tailored therapeutic approaches and facilitate personalized medicine in hematologic malignancies.

Harnessing Machine Learning for MCL Risk Prognostication With Adrian Mosquera, MD, PhD

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Harnessing Machine Learning for MCL Risk Prognostication With Adrian Mosquera, MD, PhD

Oncology Data Advisor®